VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

189 hedge funds and large institutions have $389M invested in Vanda Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 52 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+12
Holders Change %
+6.78%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
76
Reduced
52
Closed
16
Calls
$354K
Puts
$420K
Net Calls
-$66K
Net Calls Change
-$717K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$13.2M
2
BlackRock
2
BlackRock
New York
$76.3M
3
Citadel Advisors
3
Citadel Advisors
Florida
$4.05M
4
BCM
4
Bridgeway Capital Management
Texas
$2.41M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$5.94M

Top Sellers

1
Macquarie Group
1
Macquarie Group
Australia
$9.78M
2
EIP
2
Epoch Investment Partners
New York
$10.3M
3
PAI
3
Palo Alto Investors
California
$8.04M
4
Nuveen Asset Management
4
Nuveen Asset Management
Illinois
$4.23M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$21.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
MAM
201
Meeder Asset Management
Ohio
– -$2K -154 Closed
MPWT
202
MassMutual Private Wealth & Trust
Connecticut
– -$1K -85 Closed
S
203
SignatureFD
Georgia
– -$1K -71 Closed
5 6 7 8
9